What is Nanovision?
Nanovision is a pioneering technology firm focused on addressing degenerative retinal disorders that currently lack effective treatments. The company leverages advanced nanotechnology to create customized electrical neural stimulation parameters, specifically tailored to individual patient needs. This innovative approach is developed through a collaborative effort involving leading scientists, engineers, and surgeons, in partnership with the University of California, San Diego. Their cutting-edge solutions are designed to significantly improve the quality of life for individuals experiencing vision loss.
How much funding has Nanovision raised?
Nanovision has raised a total of $73K across 1 funding round:
Debt
$73K
Debt (2021): $73K with participation from PPP
Key Investors in Nanovision
PPP
Public-Private Partnership
What's next for Nanovision?
With substantial expansion capital, Nanovision is poised for accelerated growth and development. The company's strategic focus will likely involve scaling its technological capabilities, expanding clinical trials, and potentially preparing for further funding rounds to support its long-term vision restoration objectives. This investment signifies strong market confidence in Nanovision's unique approach to treating blindness.
See full Nanovision company page
